Clinical Trials Directory

Trials / Conditions / Cervical Squamous Cell Carcinoma, Not Otherwise Specified

Cervical Squamous Cell Carcinoma, Not Otherwise Specified

18 registered clinical trials studyying Cervical Squamous Cell Carcinoma, Not Otherwise Specified.

StatusTrialSponsorPhase
WithdrawnTesting the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervica
NCT03834571
AIDS Malignancy ConsortiumPhase 2
Active Not RecruitingHuman Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
NCT04574635
Mayo Clinic—
Active Not RecruitingYoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Be
NCT04622670
M.D. Anderson Cancer CenterN/A
CompletedAtezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer
NCT02921269
National Cancer Institute (NCI)Phase 2
TerminatedBiospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervi
NCT02140021
M.D. Anderson Cancer CenterN/A
TerminatedMRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
NCT01992861
University of Washington—
CompletedChemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer
NCT01711515
National Cancer Institute (NCI)Phase 1
CompletedCisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced C
NCT01414608
GOG FoundationPhase 3
CompletedVaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
NCT01266460
Gynecologic Oncology GroupPhase 2
CompletedBrivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer
NCT01267253
Gynecologic Oncology GroupPhase 2
UnknownCisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA
NCT01295502
Gynecologic Oncology GroupPhase 1
CompletedPaclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Can
NCT01281852
National Cancer Institute (NCI)Phase 1
TerminatedConservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
NCT01048853
M.D. Anderson Cancer CenterN/A
CompletedRadiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Und
NCT01101451
GOG FoundationPhase 3
CompletedGlycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing S
NCT00460356
Gynecologic Oncology Group—
CompletedBevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced
NCT00369122
National Cancer Institute (NCI)Phase 2
CompletedDocetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
NCT00041093
Gynecologic Oncology GroupPhase 2
CompletedCollecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442
Gynecologic Oncology Group—